Title

Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

Authoring Organization

Publication Month/Year

January 22, 2018

Last Updated Month/Year

June 7, 2023

Supplemental Implementation Tools

• Slide Set
• Questionnaire
• Visual Abstract
• Video
• Video

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Document Objectives

To systematically review and update the 2013 guideline to affirm its validity; to assess the evidence of new genetic discoveries, technologies, and therapies; and to issue an evidence-based update.

Inclusion Criteria

Female, Male, Adult

Health Care Settings

Hospital, Outpatient

Intended Users

Laboratory technician, genetics, nurse, nurse practitioner, physician, physician assistant

Scope

Management, Treatment

Diseases/Conditions (MeSH)

D008175 - Lung Neoplasms

Keywords

Targeted Tyrosine Kinase Inhibitors, Lung cancer treatment

Supplemental Methodology Resources

Data Supplement, Methodology Supplement